Precision Diagnostics Signed Strategic MoU with IJN University College to Advance Precision Healthcare Education, Research, and Talent Development
Global Precision Diagnostics Sdn. Bhd. (Precision Diagnostics), a leading Malaysian healthcare company specialising in precision diagnostics, pharmacogenomics, nutrigenomics, wellness laboratory services, and precision medicine, has officially signed a Memorandum of Understanding (MoU) with IJN University College (IJNUC). The partnership marks a significant step towards strengthening collaboration between industry and academia to advance healthcare education, research, and workforce development in Malaysia.
The MoU signing ceremony was attended by representatives from both organisations. Representing Precision Diagnostics were Dr. Rebecca Tay Sook Hui, Chief Executive Officer; Dr. Gew Soon Peng, Chief Operating Officer; Dr. Lee Han Chung, Director of Molecular Laboratory; Ms. Maria Phang Sue Chieng, Director of Operations, Business Development & Marketing; and Ms. Edna Tham Su Wei, Manager of Quality, Medical Affairs & Operations.
Building the Next Generation of Precision Healthcare Professionals
The collaboration will explore initiatives including industrial placements, internships, clinical attachments, scholarships, sponsorships, professional training, and career development opportunities. By providing students with greater exposure to precision diagnostics and emerging healthcare technologies, both organisations aspire to cultivate a future-ready healthcare workforce capable of supporting the evolution of personalised healthcare in Malaysia.
Advancing Research and Innovation in Precision Medicine
Research and innovation form a key pillar of this partnership. Precision Diagnostics and IJNUC will collaborate on research initiatives in pharmacogenomics (PGx), precision medicine, healthcare innovation, translational research, and other emerging areas of genomic healthcare.
Strengthening Industry-Academia Collaboration
A Shared Vision for the Future of Healthcare
“At Precision Diagnostics, we believe that advancing precision healthcare requires strong collaboration between industry and academia. By partnering with IJN University College, we hope to nurture future healthcare professionals with the knowledge, practical experience, and innovative mindset needed to drive the adoption of precision medicine. Together, we look forward to contributing to healthcare innovation, scientific research, and better patient outcomes for Malaysia.”
The MoU reflects a shared vision between Precision Diagnostics and IJN University College to strengthen healthcare education, accelerate innovation, and develop future healthcare leaders equipped to meet the evolving needs of modern medicine.
As genomic medicine becomes increasingly integrated into clinical practice, this partnership represents another important milestone in Precision Diagnostics’ ongoing commitment to advancing precision healthcare through scientific excellence, education, research, and meaningful industry collaboration.